<DOC>
	<DOCNO>NCT02701699</DOCNO>
	<brief_summary>The purpose study look low level oxygen ( hypoxia ) lung cancer use positron emission tomography ( PET ) scan . Hypoxia influence lung cancer grow respond treatment like radiotherapy chemotherapy . The use PET scan measure hypoxia may better simpler approach use previously . This study ass whether PET scan provide useful information hypoxia lung cancer . In study , radiotracer call Fluoroazomycin Arabinoside ( FAZA ) use measure hypoxia patient 's tumour . FAZA already use many cancer include lung cancer . Patients consent participate trial receive 1 FAZA PET Scan prior first radiotherapy treatment</brief_summary>
	<brief_title>18F-Fluoroazomycin Arabinoside ( 18F-FAZA ) Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1 . Age â‰¥ 18 year 2 . Patients stage II III lung cancer ( NSCLC SCLC ) qualify radiotherapy primary tumor , without treatment mediastinal hilar lymph node 3 . Intention treat use radiotherapy accord current treatment policy PMH Lung Group 4 . Concurrent systemic therapy allow 5 . A negative serum pregnancy test within two week interval immediately prior PETCT imaging , woman childbearing age 6 . Ability provide write informed consent participate study 1 . Previous radiotherapy intend treatment volume . 2 . Previous systemic therapy 3 . Active malignancy lung cancer 4 . Unable remain supine 60 minute 5 . Pregnancy 6 . Age le 18 year old 7 . Failure provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Lung Cancer</keyword>
	<keyword>FAZA PET Imaging</keyword>
	<keyword>Lung Radiotherapy</keyword>
</DOC>